Prognostic value of [18F]FLT PET in liver metastases.
- Conditions
- -resectable liver metastases of colorectal cancer-operabele levermetastasen van colorectale kanker
- Registration Number
- NL-OMON22686
- Lead Sponsor
- Department of Nuclear Medicine & PET Research VU University medical centreP.O. Box 7057, 1007 MB Amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Technically resecrable liver metastases at
the time of hepatic recurrence diagnosis;
Exclusion Criteria
1. Claustrophobia prohibiting PET-scanning;
2. Systemic cancer therapy within 3 months
prior to PET;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure: prognostic accuracy of [18F]FLT uptake in liver metastases with respect to patient outcomes (DFS).
- Secondary Outcome Measures
Name Time Method Secundary outcome measure: prognostic accuracy of [18F]FLT uptake vs. existing prognostic indices with respect to patient outcomes (DFS).